Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...

The study, published in Gastroenterology, tested a new IBS-specific blood test (InFoods IBS, Biomerica) that measures levels ...

Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...